Recognised as the leading cause of nosocomial antibiotic-associated diarrhoea, the
incidence of Clostridium difficile infection (CDI) remains high despite efforts to improve …

Clostridium difficile is primarily recognised as a nosocomially acquired pathogen
manifesting in gastrointestinal disease subsequent to the patient receiving broad-spectrum …

The bacterium originally named Bacillus difficilis was later renamed Clostridium difficile
because of the difficulty associated with its isolation in the laboratory. C. difficile causes …

Toxigenic Clostridium difficile is the etiologic agent of C. difficile-associated diarrhea
(CDAD), the most common cause of nosocomial diarrhea. Cross-infection between patients …

Clostridium difficile infection (CDI) continues to affect patients in hospitals and communities
worldwide. The spectrum of clinical disease ranges from mild diarrhoea to toxic megacolon …

Clostridium difficile is a formidable nosocomial and community-acquired pathogen, causing
clinical presentations ranging from asymptomatic colonization to self-limiting diarrhea to …

Typing of Clostridium difficile facilitates understanding of the epidemiology of the infection.
Some evaluations have shown that certain strain types (for example, ribotype 027) are more …

Clostridium difficile infection (CDI) is a leading cause of healthcare-associated infections,
accounting for significant disease burden and mortality. The clinical spectrum of C. difficile …

There has been a startling shift in the epidemiology of Clostridium difficile infection over the
last decade worldwide, and it is now increasingly recognized as a cause of diarrhea in the …

Since the early 2000s, Clostridium difficile has emerged as a major international pathogen.
Recently, strains of C. difficile in circulation appear to be changing, with greater diversity …